please supply a category in the pcf properties

Research

TTUHSC Scientist Awarded U.S. Patent to Battle Antibiotic Resistance Using Novel Nanoantibiotics

  • By Mark Hendricks
  • September 01, 2022

Hongjun Liang, Ph.D., said infection poses a significant challenge for both frontline doctors and scientists alike. It’s a challenge he wants to be able to fight by using innovation to develop a new generation of antibiotics.

Research

Research Identifies, Exploits Vulnerability in Certain High-Risk Cancers

  • By Mark Hendricks
  • August 10, 2022

In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the TTUHSC School of Medicine Cancer Center, sought to expand upon his lab’s previous research.

Research

Teaching an Old Drug New Tricks

  • By Mark Hendricks
  • July 27, 2022

Sanjay Srivastava, Ph.D., earned a U.S. patent for repurposing an antipsychotic drug to treat various types of cancer.

Research

Snail Fever Vaccine Reaches First Human Clinical Trial

  • By Kate Gollahon
  • June 10, 2022

A preventative vaccine for major tropical disease schistosomiasis has reached a Phase 1 clinical trial, providing a dose for the first healthy human volunteer.

Research

Gene Sequencing an Important Tool in COVID-19 Battle

  • By Mark Hendricks
  • June 09, 2022

Gene sequencing, a process of determining the sequential order of the building blocks that make up a strand of DNA, is used to keep pace with the constantly moving target that is COVID-19.

Research

TTUHSC Research Receives Prestigious Status as Carnegie Classification® for Special Focus Four-Year Research Institution

  • By Suzanna Cisneros
  • May 11, 2022

The Carnegie Classification® of Institutions of Higher Education has designated Texas Tech University Health Sciences Center (TTUHSC) as a Special Focus Four-Year Research Institution.

Research

TTUHSC’s Reynolds Receives CPRIT Research Grant to Study Childhood Cancers

  • By Mark Hendricks
  • April 12, 2022

CPRIT awarded a four-year, $1.34 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at the Texas Tech University Health Sciences Center.

Research

Bridging Academia and Industry to Advance Drone Technologies

  • By Suzanna Cisneros
  • April 07, 2022

Alongside Texas Tech University and 2THEDGE, a leading technology consulting and investing firm, TTUHSC unveiled the groundwork of a future public-private collaboration supporting the advancement of Unmanned Aerial Systems (UAS) research at a summit event on the TTUHSC campus Wednesday, April 6.

Research

Pharmacy Researchers Receive Patent for Chemical Probe

  • By Mark Hendricks
  • March 29, 2022

Nadia German, Ph.D., and collaborator Constantinos Mikelis, Ph.D., have received a U.S. patent for a chemical that targets the brain’s dopamine transporter.

Health

TTUHSC Researcher Receives NIH Grant to Study Vulnerabilities in Specific Cancer Types

  • By Mark Hendricks
  • March 25, 2022

The National Cancer Institute awarded a five-year, $1.9 million grant to C. Patrick Reynolds, M.D., Ph.D., director for the School of Medicine Cancer Center at TTUHSC.

Tags